New & Niche Drugs
Jan 10, 2019•14 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
We finish discussing the 2018 FDA-approvals (calaspargase, ravulizumab, tazgraxofusp).
For the best experience, listen in Metacast app for iOS or Android